Investors

Benzinga Virtual HealthCare Summit 2024

Email Alerts

Stay informed and receive company updates straight to your inbox

The press releases contained in this archive reflect information as of their original publication dates. AXIM Biotechnologies undertakes no obligation to update such information except as required by law.  Current information regarding the Company’s products and regulatory status is available on this website.

Recent News

AXIM® Biotechnologies Issues Update Letter to Shareholders

SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that it has issued a letter...

Latest Annual Filing

Fiscal Year Ended Dec 31, 2022